Low Dose Naltrexone (LDN) has been studied for many years as a novel, non-opioid treatment for chronic pain and autoimmune diseases. In this webinar, we will discuss the latest research on utilizing LDN for patients with Multiple Sclerosis, Fibromyalgia, Hashimoto's Thyroiditis, Sjögren syndrome, and many more!

Learn from your local LDN expert, Michelle Moser, RPh, FACA, FACVP. She is a long time volunteer with the LDN Research Trust, and most recently was awarded an LDN Specialist certificate. Get your questions about LDN answered here!